Charlotte Lempp

Dr. Charlotte Lempp

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2024 in Science Advances
Verified
Journal Article
Open access
CMChristoph H. Mayr
Christoph H. Mayr
DSDiana Santacruz
Diana Santacruz
SJSebastian Jarosch
Sebastian Jarosch
MBMarina Bleck
Marina Bleck
JDJohn Dalton
John Dalton
MTMatthew J. Thomas
Matthew J. Thomas
Despite advancements in antifibrotic therapy, idiopathic pulmonary fibrosis (IPF) remains a medical condition with unmet needs. Single-cell RNA sequencing (scRNA-seq) has enhanced our understanding of IPF but lacks the cellular tissue context and gene expression localization that spatial transcriptomics provides. To bridge this gap, we profiled IPF and control patient lung tissue using spatial transcriptomics, integrating the data with an IPF scRNA-seq atlas. We identified three disease-associated niches with unique cellular compositions and localizations. These include a fibrotic niche, consisting of myofibroblasts and aberrant basaloid cells, located around airways and adjacent to an airway macrophage niche in the lumen, containing SPP1 + macrophages. In addition, we identified an immune niche, characterized by distinct lymphoid cell foci in fibrotic tissue, surrounded by remodeled endothelial vessels. This spatial characterization of IPF niches will facilitate the identification of drug targets that disrupt disease-driving niches and aid in the development of disease relevant in vitro models.

27 November 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
DWDunja Wilmes
Dunja Wilmes
IMIlka McCormick-Smith
Ilka McCormick-Smith
CLCharlotte Lempp
Charlotte Lempp
UMUrsula Mayer
Ursula Mayer
ASArik Bernard Schulze
Arik Bernard Schulze
Volker RickertsVolker Rickerts
Volker Rickerts
Lack of sensitive diagnostic tests impairs the understanding of the epidemiology of histoplasmosis, a disease whose burden is estimated to be largely underrated. Broad-range PCRs have been applied to identify fungal agents from pathology blocks, but sensitivity is variable. In this study, we compared the results of a specific Histoplasma qPCR (H. qPCR) with the results of a broad-range qPCR (28S qPCR) on formalin-fixed, paraffin-embedded (FFPE) tissue specimens from patients with proven fungal infections (n = 67), histologically suggestive of histoplasmosis (n = 36) and other mycoses (n = 31). The clinical sensitivity for histoplasmosis of the H. qPCR and the 28S qPCR was 94% and 48.5%, respectively. Samples suggestive for other fungal infections were negative with the H. qPCR. The 28S qPCR did not amplify DNA of Histoplasma in FFPE in these samples, but could amplify DNA of Emergomyces (n = 1) and Paracoccidioides (n = 2) in three samples suggestive for histoplasmosis but negative in the H. qPCR. In conclusion, amplification of Histoplasma DNA from FFPE samples is more sensitive with the H. qPCR than with the 28S qPCR. However, the 28S qPCR identified DNA of other fungi in H. qPCR-negative samples presenting like histoplasmosis, suggesting that the combination of both assays may improve the diagnosis.

3 June 2024 in Toxicologic Pathology
Verified
Journal Article
Closed access
CLCharlotte Lempp
Charlotte Lempp
SAStefanie Arms
Stefanie Arms
CBChristof Albert Bertram
Christof Albert Bertram
RKRobert Klopfleisch
Robert Klopfleisch
BIBernd-Wolfgang Igl
Bernd-Wolfgang Igl
GPGabriele Pohlmeyer-Esch
Gabriele Pohlmeyer-Esch
Digitalization of pathology workflows has undergone a rapid evolution and has been widely established in the diagnostic field but remains a challenge in the nonclinical safety context due to lack of regulatory guidance and validation experience for good laboratory practice (GLP) use. One means to demonstrate that digital slides are fit for purpose, that is, provide sufficient quality for pathologists to reach a diagnosis, is conduction of comparison studies, which have been published both, for veterinary and human diagnostic pathology, but not for toxicologic pathology. Here, we present an approach that uses study material from nonclinical safety studies and that allows for the statistical comparison of concordance rates for glass and digital slide evaluation while minimizing time and effort for the involved personnel. Using a benchmark study design, we demonstrate that evaluation of digital slides fits the purpose of nonclinical safety evaluation. These results add to reports of successful workflow validations and support the full adaptation of digital pathology in the regulatory field.

28 December 2025 in Toxicologic Pathology
Verified
Journal Article
Closed access
CLCharlotte Lempp
Charlotte Lempp
EBEmmanuelle Balme
Emmanuelle Balme
RJRobert Lee Johnson
Robert Lee Johnson
AKArno Kalkuhl
Arno Kalkuhl
SPSmitha Pillai
Smitha Pillai
TNThomas Nolte
Thomas Nolte
The 31st edition of the slide seminar “Classic Examples in Toxicologic Pathology” was held at the Department of Pathology at the University of Veterinary Medicine in Hannover, Germany, in March 2024. The meeting series is jointly organized with the ESTP (European Society of Toxicologic Pathology) and aims at presenting and discussing classical and novel cases of toxicologic and experimental pathology. This article reflects on 6 out of 10 presentations given at the seminar and includes images of representative lesions. They comprise cases of toxicologic pathology, induced directly or indirectly by a test item. We herein summarize findings with a progesterone receptor antagonist and its impact on uterine tumor development in rats; an example of hybridization-dependent off-target hepatotoxicity in rats administered a small interfering RNA (siRNA) conjugated to N-acetylgalactosamine (GalNAc) and the case of an orexin-1/-2 receptor antagonist with liver enzyme induction. We further include a case on reactive metabolites with associated liver findings, a study on findings induced by a GPR40 agonist and a presentation on dysgeusia and its translatability.